(2S,4R)-1-((S)-2-((2-(2-(2-(4-(((2-fluoro-3-((4-methyl-2-oxo-7-(pyrimidin-2-yloxy)-2H-chromen-3-yl)methyl)phenyl)amino)methyl)-1H-1,2,3-triazol-1-yl)ethoxy)ethoxy)ethyl)amino)-3,3-dimethylbutanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide

ID: ALA5280188

Chembl Id: CHEMBL5280188

Max Phase: Preclinical

Molecular Formula: C53H61FN10O8S

Molecular Weight: 1017.20

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NCCOCCOCCn2cc(CNc3cccc(Cc4c(C)c5ccc(Oc6ncccn6)cc5oc4=O)c3F)nn2)C(C)(C)C)cc1

Standard InChI:  InChI=1S/C53H61FN10O8S/c1-32-41-16-15-40(71-52-56-17-8-18-57-52)27-45(41)72-51(68)42(32)25-37-9-7-10-43(46(37)54)58-28-38-29-63(62-61-38)20-22-70-24-23-69-21-19-55-48(53(4,5)6)50(67)64-30-39(65)26-44(64)49(66)60-33(2)35-11-13-36(14-12-35)47-34(3)59-31-73-47/h7-18,27,29,31,33,39,44,48,55,58,65H,19-26,28,30H2,1-6H3,(H,60,66)/t33-,39+,44-,48+/m0/s1

Standard InChI Key:  DHACDBHLGBCXSX-WQWWALRQSA-N

Alternative Forms

  1. Parent:

    ALA5280188

    ---

Associated Targets(Human)

MAP2K2 Tclin VHL-MAP2K1/MAP2K2 (64 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1017.20Molecular Weight (Monoisotopic): 1016.4379AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Wang C, Wang H, Zheng C, Li B, Liu Z, Zhang L, Yuan L, Xu P..  (2023)  Discovery of Coumarin-Based MEK1/2 PROTAC Effective in Human Cancer Cells.,  14  (1.0): [PMID:36655129] [10.1021/acsmedchemlett.2c00446]

Source